drugset / Press release
Emergent BioSolutions' Otlertuzumab (TRU-016) Shows Positive Results in Combination with Rituximab in People with CLL
2013-12-10 · Emergent BioSolutions · original emergentbiosolutions.com ↗
121013 - EBS Presents Ph1b Data Otlertuzumab Rituximab in FL CLL FINAL.pdf 203.8 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗